Literature DB >> 34405450

The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis.

Ting Chen1,2, Jia-Ling Wei1,2, Ting Leng1,2, Fei Gao1,2, Shun-Yu Hou1,2.   

Abstract

BACKGROUND: We aimed to analyze the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people, and establish a more efficient combined diagnostic model.
METHODS: We retrospectively analyzed the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people. Binary logistic regression analysis was used to establish a combined diagnostic model. We plotted the receiver operator characteristic (ROC) curve to analyze the diagnostic efficiency of different diagnostic indexes.
RESULTS: Compared with patients in the control group, patients in the endometriosis group had significantly lower eosinophil% (p = 0.045), neutrophil (p = 0.001), lymphocyte (p < 0.001), red blood cells (RBCs) (p < 0.001), and hemoglobin (HGB) (p < 0.001), and had significantly higher monocyte% (p = 0.008), monocyte-to-lymphocyte ratio (MLR) (p = 0.001), platelet-to-lymphocyte ratio (PLR) (p < 0.001), carbohydrate antigen (CA)-199 (p < 0.001), CA125 (p < 0.001), human epididymis protein (HE)-4 (p < 0.001), and the risk of ovarian malignancy algorithm (ROMA) (p < 0.001). The combined diagnostic model of HGB, CA199, CA125, and HE4 was established by binary logistic regression analysis. The ROC curve showed that the combined diagnostic model reached a sensitivity of 85.4%, a specificity of 78.83%, and an area under the curve of 0.900, which was significantly higher than that of the individual index in endometriosis diagnosis.
CONCLUSION: The combined diagnostic model of HGB, CA199, CA125, and HE4 may provide a new approach for the early non-invasive diagnosis of endometriosis.
© 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

Entities:  

Keywords:  CA125; CA199; HE4; HGB; endometriosis

Mesh:

Substances:

Year:  2021        PMID: 34405450      PMCID: PMC8418510          DOI: 10.1002/jcla.23947

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  23 in total

Review 1.  Peripheral biomarkers of endometriosis: a systematic review.

Authors:  K E May; S A Conduit-Hulbert; J Villar; S Kirtley; S H Kennedy; C M Becker
Journal:  Hum Reprod Update       Date:  2010-05-12       Impact factor: 15.610

2.  Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy.

Authors:  Ignacio Zapardiel; Mikel Gorostidi; Antonella Ravaggi; Maria T Allende; Margarida Silveira; Daniel Abehsera; Ronalds Macuks
Journal:  Int J Gynecol Cancer       Date:  2016-01       Impact factor: 3.437

3.  Endometriosis: correlation between histologic and visual findings at laparoscopy.

Authors:  A J Walter; J G Hentz; P M Magtibay; J L Cornella; J F Magrina
Journal:  Am J Obstet Gynecol       Date:  2001-06       Impact factor: 8.661

4.  Recurrent endometriosis: a battle against an unknown enemy.

Authors:  Marcello Ceccaroni; Valentina Elisabetta Bounous; Roberto Clarizia; Daniele Mautone; Mohamed Mabrouk
Journal:  Eur J Contracept Reprod Health Care       Date:  2019-09-25       Impact factor: 1.848

Review 5.  The social and psychological impact of endometriosis on women's lives: a critical narrative review.

Authors:  Lorraine Culley; Caroline Law; Nicky Hudson; Elaine Denny; Helene Mitchell; Miriam Baumgarten; Nick Raine-Fenning
Journal:  Hum Reprod Update       Date:  2013-07-24       Impact factor: 15.610

Review 6.  Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis.

Authors:  M Hirsch; Jmn Duffy; C J Davis; M Nieves Plana; K S Khan
Journal:  BJOG       Date:  2016-05-12       Impact factor: 6.531

7.  ESHRE guideline for the diagnosis and treatment of endometriosis.

Authors:  Stephen Kennedy; Agneta Bergqvist; Charles Chapron; Thomas D'Hooghe; Gerard Dunselman; Robert Greb; Lone Hummelshoj; Andrew Prentice; Ertan Saridogan
Journal:  Hum Reprod       Date:  2005-06-24       Impact factor: 6.918

Review 8.  Endometriosis: a high-risk population for major chronic diseases?

Authors:  Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer
Journal:  Hum Reprod Update       Date:  2015-03-11       Impact factor: 15.610

9.  Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study.

Authors:  Hee Seung Kim; Hwa-Young Choi; Maria Lee; Dong Hoon Suh; Kidong Kim; Jae Hong No; Hyun Hoon Chung; Yong Beom Kim; Yong Sang Song
Journal:  Cancer Res Treat       Date:  2015-03-06       Impact factor: 4.679

View more
  3 in total

1.  The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis.

Authors:  Ting Chen; Jia-Ling Wei; Ting Leng; Fei Gao; Shun-Yu Hou
Journal:  J Clin Lab Anal       Date:  2021-08-18       Impact factor: 2.352

Review 2.  A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis.

Authors:  Xiaolin Qing; Liting Liu; Xiguang Mao
Journal:  Comput Math Methods Med       Date:  2022-05-25       Impact factor: 2.809

3.  Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer.

Authors:  Li Ning; Jinghe Lang; Lingying Wu
Journal:  BMC Cancer       Date:  2022-01-03       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.